• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

银屑病和克罗恩病中的肠道微生物群:其扰动是它们发病机制的共同因素吗?

The Gut Microbiome in Psoriasis and Crohn's Disease: Is Its Perturbation a Common Denominator for Their Pathogenesis?

作者信息

De Francesco Maria Antonia, Caruso Arnaldo

机构信息

Institute of Microbiology, Department of Molecular and Translational Medicine, University of Brescia-Spedali Civili, P. le Spedali Civili, 1, 25123 Brescia, Italy.

出版信息

Vaccines (Basel). 2022 Feb 5;10(2):244. doi: 10.3390/vaccines10020244.

DOI:10.3390/vaccines10020244
PMID:35214702
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8877283/
Abstract

Psoriasis and inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn's disease (CD), are interlinked. In fact, the prevalence of IBD is higher in patients with psoriasis, with a risk of ulcerative colitis of 1.6-times higher than in the general population. Analogously, patients with psoriasis have a greater risk of developing IBD. Furthermore, they share some clinical features and pathogenic mechanisms. Both are chronic inflammatory diseases with a relapsing-remitting condition that persists for the patient's whole life and exhibit increased permeability of the mucosal barrier of skin and gut, allowing an increased interaction of pathogens with inflammatory receptors of the immune cells. A key element in the pathogenesis of these diseases is represented by the microbiota; in particular, the gut microbiota is an important driver of CD pathogenesis, while in psoriasis changes in gut and skin microbiota have been described without a defined pathogenic function. Furthermore, genetic predispositions or environmental factors contribute to disease manifestation, with a central role attributed to the immune responses and, in particular, to a dysregulated role played by T helper 17 cells both in psoriasis and IBD. The purpose of this review was to summarize present information about the links between psoriasis, inflammatory bowel disease, in particular Crohn's disease, and changes in gut and/or skin microbiome.

摘要

银屑病与炎症性肠病(IBD),包括溃疡性结肠炎(UC)和克罗恩病(CD),相互关联。事实上,银屑病患者中IBD的患病率更高,溃疡性结肠炎的发病风险比普通人群高1.6倍。同样,银屑病患者患IBD的风险也更高。此外,它们具有一些共同的临床特征和致病机制。二者均为慢性炎症性疾病,呈复发-缓解状态,会伴随患者终生,且皮肤和肠道黏膜屏障的通透性增加,使得病原体与免疫细胞的炎症受体之间的相互作用增强。这些疾病发病机制中的一个关键因素是微生物群;特别是,肠道微生物群是CD发病机制的重要驱动因素,而在银屑病中,肠道和皮肤微生物群的变化已有描述,但尚未明确其致病功能。此外,遗传易感性或环境因素也会导致疾病表现,免疫反应,尤其是辅助性T细胞17在银屑病和IBD中发挥的失调作用,在其中起到了核心作用。本综述的目的是总结目前关于银屑病、炎症性肠病,特别是克罗恩病,以及肠道和/或皮肤微生物群变化之间联系的相关信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4de/8877283/7cfaf6cdb328/vaccines-10-00244-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4de/8877283/7cfaf6cdb328/vaccines-10-00244-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4de/8877283/7cfaf6cdb328/vaccines-10-00244-g001.jpg

相似文献

1
The Gut Microbiome in Psoriasis and Crohn's Disease: Is Its Perturbation a Common Denominator for Their Pathogenesis?银屑病和克罗恩病中的肠道微生物群:其扰动是它们发病机制的共同因素吗?
Vaccines (Basel). 2022 Feb 5;10(2):244. doi: 10.3390/vaccines10020244.
2
Functional Characterization of Inflammatory Bowel Disease-Associated Gut Dysbiosis in Gnotobiotic Mice.无菌小鼠中炎症性肠病相关肠道菌群失调的功能特征
Cell Mol Gastroenterol Hepatol. 2016 Mar 3;2(4):468-481. doi: 10.1016/j.jcmgh.2016.02.003. eCollection 2016 Jul.
3
The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.炎症、营养供应和共生微生物群在肠道病原体感染中的作用。
Microbiol Spectr. 2015 Jun;3(3). doi: 10.1128/microbiolspec.MBP-0008-2014.
4
Inflammatory bowel disease and psoriasis: modernizing the multidisciplinary approach.炎症性肠病与银屑病:多学科方法的现代化。
J Intern Med. 2021 Aug;290(2):257-278. doi: 10.1111/joim.13282. Epub 2021 May 4.
5
Psoriasis and inflammatory bowel disease: links and risks.银屑病与炎症性肠病:关联与风险
Psoriasis (Auckl). 2016 Jul 20;6:73-92. doi: 10.2147/PTT.S85194. eCollection 2016.
6
Alteration of Gut Microbiota in Inflammatory Bowel Disease (IBD): Cause or Consequence? IBD Treatment Targeting the Gut Microbiome.炎症性肠病(IBD)中肠道微生物群的改变:原因还是后果?针对肠道微生物群的IBD治疗靶点
Pathogens. 2019 Aug 13;8(3):126. doi: 10.3390/pathogens8030126.
7
Diet and gut microbiota manipulation for the management of Crohn's disease and ulcerative colitis.用于治疗克罗恩病和溃疡性结肠炎的饮食及肠道微生物群调控
Proc Nutr Soc. 2021 Sep 23:1-15. doi: 10.1017/S0029665121002846.
8
Alterations in Gut Microbial Communities Across Anatomical Locations in Inflammatory Bowel Diseases.炎症性肠病不同解剖部位肠道微生物群落的改变
Front Nutr. 2021 Feb 26;8:615064. doi: 10.3389/fnut.2021.615064. eCollection 2021.
9
Highlighting the Relevance of Gut Microbiota Manipulation in Inflammatory Bowel Disease.强调肠道微生物群调控在炎症性肠病中的相关性。
Diagnostics (Basel). 2021 Jun 15;11(6):1090. doi: 10.3390/diagnostics11061090.
10
Gut microbiota in the pathogenesis of inflammatory bowel disease.肠道微生物群在炎症性肠病发病机制中的作用
Clin J Gastroenterol. 2018 Feb;11(1):1-10. doi: 10.1007/s12328-017-0813-5. Epub 2017 Dec 29.

引用本文的文献

1
Exploring the Therapeutic and Gut Microbiota-Modulating Effects of Qingreliangxuefang on IMQ-Induced Psoriasis.探索清热凉血方对咪喹莫特诱导的银屑病的治疗及肠道微生物群调节作用。
Drug Des Devel Ther. 2025 Apr 28;19:3269-3291. doi: 10.2147/DDDT.S492044. eCollection 2025.
2
Anti-Psoriatic Efficacies of Psorogrit and Divya-Taila, in Murine Models of Imiquimod and TPA-Induced Psoriasis-Like Inflammation are Driven by Modulation in IL-17RA/IL-23 and IL-8/TNF-α Signaling Axes.补骨脂和迪维亚油在咪喹莫特和TPA诱导的银屑病样炎症小鼠模型中的抗银屑病功效是由IL-17RA/IL-23和IL-8/TNF-α信号轴的调节驱动的。
J Inflamm Res. 2025 Apr 18;18:5235-5259. doi: 10.2147/JIR.S505245. eCollection 2025.
3

本文引用的文献

1
The Cytokine Mediated Molecular Pathophysiology of Psoriasis and Its Clinical Implications.细胞因子介导的银屑病分子病理生理学及其临床意义。
Int J Mol Sci. 2021 Nov 26;22(23):12793. doi: 10.3390/ijms222312793.
2
The skin microbiome in psoriatic disease: A systematic review and critical appraisal.银屑病性疾病中的皮肤微生物群:一项系统评价与批判性评估
J Transl Autoimmun. 2019 Aug 20;2:100009. doi: 10.1016/j.jtauto.2019.100009. eCollection 2019 Dec.
3
Biologics in the treatment of pustular psoriasis.生物制剂治疗脓疱型银屑病。
Gut Microbiota Dysbiosis: Pathogenesis, Diseases, Prevention, and Therapy.
肠道微生物群失调:发病机制、疾病、预防与治疗
MedComm (2020). 2025 Apr 18;6(5):e70168. doi: 10.1002/mco2.70168. eCollection 2025 May.
4
Psoriasis and inflammatory bowel disease: concomitant IMID or paradoxical therapeutic effect? A scoping review on anti-IL-12/23 and anti-IL-23 antibodies.银屑病与炎症性肠病:是合并存在的免疫介导性炎症性疾病还是矛盾的治疗效果?关于抗IL-12/23和抗IL-23抗体的综述
Therap Adv Gastroenterol. 2024 Nov 21;17:17562848241299564. doi: 10.1177/17562848241299564. eCollection 2024.
5
Intestinal Permeability In Subjects With Rheumatoid Arthritis: A Critical Therapeutic Priority.类风湿关节炎患者的肠道通透性:一个关键的治疗重点。
Integr Med (Encinitas). 2024 Nov;23(5):16-26.
6
Efficacy and Safety of Cannabis Transdermal Patch for Alleviating Psoriasis Symptoms: Protocol for a Randomized Controlled Trial (CanPatch).大麻透皮贴剂缓解银屑病症状的疗效与安全性:一项随机对照试验(CanPatch)方案
Med Cannabis Cannabinoids. 2024 May 30;7(1):99-110. doi: 10.1159/000539492. eCollection 2024 Jan-Dec.
7
Atopic dermatitis and food allergy: More than sensitization.特应性皮炎和食物过敏:不仅仅是致敏。
Mucosal Immunol. 2024 Oct;17(5):1128-1140. doi: 10.1016/j.mucimm.2024.06.005. Epub 2024 Jun 19.
8
Krill Oil and Its Bioactive Components as a Potential Therapy for Inflammatory Bowel Disease: Insights from In Vivo and In Vitro Studies.磷虾油及其生物活性成分作为炎症性肠病的潜在疗法:来自体内和体外研究的见解
Biomolecules. 2024 Apr 6;14(4):447. doi: 10.3390/biom14040447.
9
IL-17A inhibitors alleviate Psoriasis with concomitant restoration of intestinal/skin microbiota homeostasis and altered microbiota function.白细胞介素-17A 抑制剂可缓解银屑病,同时恢复肠道/皮肤微生物群落平衡和改变微生物群落功能。
Front Immunol. 2024 Feb 28;15:1344963. doi: 10.3389/fimmu.2024.1344963. eCollection 2024.
10
is a potential marker of altered gut microbiota in psoriasis and psoriatic arthritis.是银屑病和银屑病关节炎中肠道微生物改变的潜在标志物。
Microbiol Spectr. 2024 Apr 2;12(4):e0115423. doi: 10.1128/spectrum.01154-23. Epub 2024 Mar 5.
Expert Opin Drug Saf. 2020 Aug;19(8):969-980. doi: 10.1080/14740338.2020.1785427. Epub 2020 Jul 2.
4
Is Psoriasis Treatment a Risk Factor for Inflammatory Bowel Disease?银屑病治疗是否会增加炎症性肠病的风险?
Pharmaceut Med. 2020 Aug;34(4):257-262. doi: 10.1007/s40290-020-00340-1.
5
Pathophysiology, Clinical Presentation, and Treatment of Psoriasis: A Review.银屑病的病理生理学、临床表现和治疗:综述。
JAMA. 2020 May 19;323(19):1945-1960. doi: 10.1001/jama.2020.4006.
6
Crohn's disease.克罗恩病。
Nat Rev Dis Primers. 2020 Apr 2;6(1):22. doi: 10.1038/s41572-020-0156-2.
7
Inverse Psoriasis: From Diagnosis to Current Treatment Options.反向性银屑病:从诊断到当前的治疗选择
Clin Cosmet Investig Dermatol. 2019 Dec 31;12:953-959. doi: 10.2147/CCID.S189000. eCollection 2019.
8
Gut Microbiota and the Alteration of Immune Balance in Skin Diseases: From Nutraceuticals to Fecal Transplantation.肠道微生物群与皮肤病中免疫平衡的改变:从营养保健品到粪便移植
Open Access Maced J Med Sci. 2019 Sep 12;7(18):3034-3038. doi: 10.3889/oamjms.2019.827. eCollection 2019 Sep 30.
9
The Skin and Gut Microbiome and Its Role in Common Dermatologic Conditions.皮肤与肠道微生物群及其在常见皮肤病中的作用
Microorganisms. 2019 Nov 11;7(11):550. doi: 10.3390/microorganisms7110550.
10
Global Prevalence and Bidirectional Association Between Psoriasis and Inflammatory Bowel Disease-A Systematic Review and Meta-analysis.银屑病与炎症性肠病的全球患病率及双向关联:系统评价和荟萃分析。
J Crohns Colitis. 2020 Mar 13;14(3):351-360. doi: 10.1093/ecco-jcc/jjz152.